drugset / Trial / NCT04007055
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
RandomizedParallel-groupOpen-labelScreening
Summary
This is a randomized controlled trial designed to evaluate the role of screening for and intervening on patients with high on treatment platelet reactivity undergoing lower extremity arterial endovascular interventions.
Timeline
- Start
- 2019-08-09
- Primary completion
- 2023-03-28
- Completion
- 2024-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ticagrelor | Small molecule | 90 mg | — |